Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,672 signal articles · 40 in last 24h · 156,038 total before filter · latest 46m ago
40last 24h
851last 7d
149● bullish (7d)
86● bearish (7d)
214publishers
AllMacro188Earnings112M&A123Regulatory20Product19Analyst21
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Investing.com31d agobullish
Amkor Tech jumps 9% as BofA initiates Buy with $70 target on AI surge

Investing.com -- Amkor Technology (NASDAQ: AMKR) popped 9% on Thursday after BofA Securities initiated coverage on the semiconductor packaging giant with a "Buy" rating and a bullish $70 price target—representing a massive 45% upside from its August 26 closing price of $48.40. Driving the upgrade is Amkor’s pivotal positioning in the artificial intelligence supply chain, alongside a broader structural shift toward domestic chip manufacturing. "We see AMKR as an underappreciated beneficiary of ri

Best Buy Raises Outlook as Sales Grow
The Wall Street Journal31d agobullish
Best Buy Raises Outlook as Sales Grow

The company now forecasts full-year adjusted earnings per share of $6.70 to $6.90, up from its prior guidance of $6.30 to $6.60.

3 Energy Stocks With Big Dividends to Buy Now
24/7 Wall St.31d agobullish
3 Energy Stocks With Big Dividends to Buy Now

Midstream energy is quietly printing some of the fattest, most reliable income checks in the market right now, and three pipeline giants are leading the charge with raised payouts, record cash flows, and growth backlogs that stretch years into the future.

Salesforce shares surge as AI growth powers strong Q2 and upgraded outlook
InvestorsHub31d agobullish
Salesforce shares surge as AI growth powers strong Q2 and upgraded outlook

Salesforce (NYSE:CRM) shares jumped 11% in US premarket trading on Thursday after the enterprise software group delivered second-quarter results ahead of Wall Street expectations, supported by rapidly expanding artificial intelligence demand, stronger profitability and robust cash generation. Adjusted earnings reached $5.

Tempus AI (TEM) Wins FDA Clearance For ECG Tool That Flags Pulmonary Hypertension
Simply Wall St.31d agobullish
Tempus AI (TEM) Wins FDA Clearance For ECG Tool That Flags Pulmonary Hypertension

Tempus AI (NasdaqGS:TEM) received FDA 510(k) clearance for Tempus ECG-PH, an AI-enabled tool that flags signs of pulmonary hypertension from standard ECGs. The newly cleared product is the third FDA-cleared offering in Tempus AI's cardiovascular portfolio, expanding the company beyond its core oncology genomics focus. Tempus ECG-PH is designed to help clinicians identify a condition that can be challenging to diagnose using conventional methods, addressing a key unmet need in cardiovascular...